Terms: = Head and neck cancer AND FEV, Pet-1, 54738, ENSG00000163497, PET-1, HSRNAFEV AND Prognosis
3 results:
1. Stage II oesophageal carcinoma: peril in disguise associated with cellular reprogramming and oncogenesis regulated by pseudogenes.
Pravallika G; Rajasekaran R
BMC Genomics; 2024 Feb; 25(1):135. PubMed ID: 38308202
[TBL] [Abstract] [Full Text] [Related]
2. I-PET score: Combining whole body iodine and
Wijewardene A; Hoang J; Maw AM; Gild M; Tacon L; Roach P; Schembri G; Chan D; Clifton-Bligh R
Clin Endocrinol (Oxf); 2023 Mar; 98(3):436-446. PubMed ID: 35918798
[TBL] [Abstract] [Full Text] [Related]
3. Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.
Lorenzen S; von Gall C; Stange A; Haag GM; Weitz J; Haberkorn U; Lordick F; Weichert W; Abel U; Debus J; Jäger D; Münter MW
BMC Cancer; 2011 Jun; 11():266. PubMed ID: 21702914
[TBL] [Abstract] [Full Text] [Related]
